All articles tagged with #medicare
Originally Published 1 day ago — by Politico
The article discusses skepticism around Trump's proposed plan to pressure insurers into lowering prices, with critics arguing it oversimplifies a complex healthcare issue and may not lead to significant relief for families, while some politicians remain cautiously optimistic.
Originally Published 9 days ago — by Yahoo
Drugmakers plan to raise prices on at least 350 medicines in the U.S., including vaccines and cancer treatments, despite pressure from the Trump administration to lower costs, with some drugs also seeing significant price cuts. The increases are part of ongoing strategies to maximize profits amid regulatory and political scrutiny, while some companies adjust prices to keep pace with inflation and support innovation.
Originally Published 10 days ago — by CNN
Drugmakers plan to raise prices on at least 350 medicines in the US for 2026, including vaccines and cancer treatments, despite pressure from the Trump administration to lower costs. While some drugs will see price cuts, overall prices are increasing, with companies like Pfizer and GSK citing the need to support innovation and cover costs. These hikes occur even as the US continues to pay significantly more for prescription drugs compared to other developed nations.
Originally Published 11 days ago — by TRICARE Newsroom (.mil)
TRICARE For Life moves with beneficiaries whether they move within the U.S. or overseas, requiring updates to addresses in DEERS, Social Security, and TRICARE systems. It provides Medicare-wraparound coverage, with specific procedures for care and prescriptions in new locations, including overseas. Beneficiaries should explore provider options, update their information, and understand coverage details, especially when moving abroad or within the U.S. territories.
Originally Published 17 days ago — by Axios
Nineteen states and D.C. sued HHS Secretary Robert F. Kennedy Jr. to block his plan to stop Medicare and Medicaid payments for gender-affirming care for minors, arguing it exceeds his authority and violates laws, while major medical organizations support such care as necessary and lifesaving for transgender youth.
Originally Published 24 days ago — by VTDigger
The U.S. Department of Health and Human Services, led by Secretary Robert F. Kennedy Jr., proposed new rules that could prohibit hospitals participating in Medicaid and Medicare from providing gender-affirming care to minors, potentially impacting Vermont's protections and access to such care. Vermont officials and medical providers have expressed strong support for maintaining access, while advocates warn that the rules could threaten federal funding and legal challenges are expected.
Originally Published 25 days ago — by Bloomberg.com
Hospitals in the US are significantly marking up the prices of old, generic cancer drugs, sometimes by hundreds of times the Medicare rate, leading to inflated costs for patients and insurers. This practice, driven by hospital profit motives and opaque pricing systems, results in substantial financial burdens on patients and health plans, despite the drugs being inexpensive to produce. Efforts to increase price transparency and regulate these markups are ongoing, but the problem remains complex and widespread.
Originally Published 26 days ago — by CNBC
President Trump is expected to sign an executive order reclassifying cannabis as a Schedule III drug, which could expand access to CBD products, include Medicare coverage for seniors, and significantly impact the cannabis industry, research, and investments, despite ongoing scientific and regulatory debates.
Originally Published 2 months ago — by The Boston Globe
A study published in JAMA Health Forum reports a 27% increase in premature deaths among Americans aged 18-64 from 2012 to 2022, with significant disparities by race and location, highlighting that more people are dying before they can access Medicare at age 65.
Originally Published 2 months ago — by Barron's
Insurers and hospital stocks declined as a government shutdown deal moved forward without extending health-insurance subsidies, risking increased uninsured Americans and higher premiums, with prospects for extension looking bleak amid political disagreements.
Originally Published 2 months ago — by TipRanks
Eli Lilly's stock (LLY) was upgraded following news that obesity drugs will now be covered by Medicare, potentially boosting the company's prospects in the pharmaceutical industry.
Originally Published 2 months ago — by statnews.com
Starting in January, UnitedHealthcare will cease paying physicians for remote monitoring of chronic conditions like hypertension, citing insufficient evidence of efficacy, which impacts many members and follows recent criticism over coverage decisions; exceptions include monitoring for heart failure and hypertensive disorders during pregnancy.
Originally Published 2 months ago — by The Washington Post
A new study reveals that more people are dying before age 65, raising concerns about the effectiveness of healthcare and safety nets for younger populations, and highlighting potential shifts in health trends and risks.
Originally Published 2 months ago — by Axios
Medicare will now cover weight-loss drugs like Ozempic and Wegovy through a deal with Eli Lilly and Novo Nordisk, significantly reducing costs and expanding access for seniors and certain high-risk groups, starting with a pilot program in 2026.
Originally Published 2 months ago — by Bloomberg.com
Eli Lilly and Novo Nordisk have reached deals with the Trump administration to lower prices for their weight-loss drugs like Zepbound and Wegovy, making them more accessible to Medicare patients and receiving tariff relief, with the aim of expanding access and reducing costs for millions of Americans.